Aibotics, INC. (AIBT) — 10-Q Filings

All 10-Q filings from Aibotics, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

AIBOTICS' Losses Widen Amidst Minimal Revenue, Going Concern Doubt — Nov 19, 2025 Risk: high
AIBOTICS, INC. (AIBT) reported a net loss of $1,607,467 for the nine months ended September 30, 2025, an increase from a net loss of $1,356,761 in the same peri
AIBOTICS, INC. Files Q2 2025 10-Q Report — Aug 19, 2025 Risk: low
AIBOTICS, INC. filed its quarterly report for the period ending June 30, 2025. The company, formerly known as Mycotopia Therapies, Inc. and 20/20 Global, Inc.,
AIBOTICS, INC. Files Q1 2025 10-Q — May 20, 2025 Risk: low
AIBOTICS, INC. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Mycotopia Therapies, Inc. and 20/20 Global, Inc., is in the m
Mycotopia Therapies Files Q3 2024 10-Q Report — Nov 14, 2024 Risk: medium
Mycotopia Therapies, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2024. The company, previously known as 20/20 Global, Inc.,
Mycotopia Therapies Files Q2 2024 10-Q — Aug 19, 2024 Risk: medium
Mycotopia Therapies, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as 20/20 Global, Inc., is incorporated in Nevada and o
Mycotopia Therapies, Inc. Files Form 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
Mycotopia Therapies, Inc. (AIBT) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Mycotopia Therapies, Inc. filed a Form 10-Q for the quarterly per

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX